Assessing the metabolism of the olfactory circuit by use of 18F-FDG PET-CT imaging in patients suspected of suffering from Alzheimer's disease or frontotemporal dementia

Daniël S. L. Loewenstein,Max van Grinsven,Cécile de Pont,Paul L. J. Dautzenberg,Astrid M. van Strien,Dylan Henssen
DOI: https://doi.org/10.1186/s13195-024-01604-7
2024-10-30
Alzheimer s Research & Therapy
Abstract:The loss of olfactory function is known to occur in patients suffering from (behavioral variant) frontotemporal dementia ((bv)FTD) and Alzheimer's disease (AD), although different pathophysiological mechanisms underpin this clinical symptom in both disorders. This study assessed whether brain metabolism of the olfactory circuit as assessed by positron emission tomography (PET) imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose ([ 18 F]-FDG) can distinguish these entities in different subsets of patients.
neurosciences,clinical neurology
What problem does this paper attempt to address?